Trichloroacetic acid
Trichloroacetic acid has been studied in 2 papers since 2025: 1 trial in people; 1 in the past year. The newest paper, Nov 19, 2026: “Comparative cost-effectiveness of HPV mRNA and DNA testing for anal cancer screening in MSM living with HIV: a model-based study”.
1 new paper in 30 daysSee all 3 papers on trichloroacetic acid
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“All patients who completed their full treatment course entered clinical remission following their trichloroacetic acid treatment”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
- In silico1
Studies in people
1 study gave trichloroacetic acid to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases actinic cheilitis3.2 to 1.1 up: Improves quality of life | Treated cohort1‐month intervals for a maximum of three treatments | 11 peoplepredominantly male (n = 7, 64%)average age was 66.7 years (SD = 9.8)Patients with actinic cheilitis presenting to our institution | OTO open, May 23, 2025 |
What did studies of trichloroacetic acid find?
2Studies of trichloroacetic acid measured 2 outcomes: actinic cheilitis and quality of life.
Actinic cheilitis
downin humans1
1 study
Actinic cheilitis
downin humans1
Trichloroacetic acid decreases actinic cheilitis in humans (3.2 to 1.1).
Human trialtopicallower lip1‐month intervals for a maximum of three treatmentsn = 11
Trichloroacetic acid decreases actinic cheilitis in humans (actinic cheilitis).
Human trialactinic cheilitispeellower lip35%n = 11
Quality of life
upin humans1
1 study
Quality of life
upin humans1
Trichloroacetic acid improves quality of life in humans.
Human trialtopicallower lip1‐month intervals for a maximum of three treatmentsn = 11